- feeds
- popular
- recent
- reader
- about
- story
- technologies
- what is rss
- connect
- dmca
- contact
- Feed Preview PMLiVE
Johnson & Johnson to expand dermatology portfolio with $850m Proteologix acquisition
The company will gain access to two treatments for atopic dermatitis
GSK becomes first founding partner of global initiative tackling antimicrobial resistance
AMR could cause an estimated ten million deaths every year by 2050 unless action is taken
Governments continue proposed pandemic agreement progress ahead of World Health Assembly
The meeting focusing on ‘All for Health, Health for All’ takes place on 27 May to 7 June 2024
Study reveals new breast cancer genes found in women of African ancestry
More than 240,000 cases of breast cancer are diagnosed in the US every year
The PM Society announces Sumira Riaz as Patient Engagement Interest Group co-chair
Riaz has been working as a patient engagement lead at OPEN Health for the last seven years
Bristol Myers Squibb’s Breyanzi granted FDA accelerated approval for follicular lymphoma
The disease accounts for up to 30% of all non-Hodgkin lymphoma cases
Takeda’s Qdenga becomes second dengue vaccine to receive WHO prequalification
Approximately half of the global population is at risk of mosquito-borne viral disease
AstraZeneca’s sipavibart shown to prevent COVID-19 in immunocompromised patients
Immunocompromised individuals account for about 25% of COVID-19 hospitalisations, intensive care unit admissions and deaths
UCB shares positive phase 3 results for Zilbrysq in generalised myasthenia gravis
Zilbrysq is the first C5 inhibitor to show a clinically meaningful reduction of fatigue in the rare autoimmune disease
Sanofi gains rights to Fulcrum’s muscular dystrophy treatment in deal worth more than $1bn
Losmapimod is being investigated as a potential transformative therapy for the rare disease